Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydroxamic acid hybrids as the potential anticancer agents: An Overview
Wenhua Liu, Yuchen Liang, Xiaoyong Si
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112679-112679
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
Xin-Hui Zhang, Qin-Ma, Hui-Pan Wu, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 3, pp. 1362-1391
Closed Access | Times Cited: 99
FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review
Aleksandra Sochacka-Ćwikła, Marcin Mączyński, Andrzej Regiec
Cancers (2021) Vol. 14, Iss. 1, pp. 87-87
Open Access | Times Cited: 62
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets
Antonino Lauria, Gabriele La Monica, Alessia Bono, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113555-113555
Closed Access | Times Cited: 61
Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)
Jiaqi Xiao, Meixiang Gao, Zhou Sun, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112830-112830
Closed Access | Times Cited: 56
Sunlight‐ or UVA‐Light‐Mediated Synthesis of Hydroxamic Acids from Carboxylic Acids
Olga G. Mountanea, Christiana Mantzourani, Maroula G. Kokotou, et al.
European Journal of Organic Chemistry (2023) Vol. 26, Iss. 13
Open Access | Times Cited: 15
Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds
Mingxue Zhang, Xiaoqin Dai, Yu Xiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115546-115546
Closed Access | Times Cited: 9
Hybridization of Imidazole with Various Heterocycles in Targeting Cancer: A Decade's Work
Ghanshyam Teli, Pooja A. Chawla
ChemistrySelect (2021) Vol. 6, Iss. 19, pp. 4803-4836
Closed Access | Times Cited: 21
Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency
Yuan Jiang Pan, Haodong Hou, Bo Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115879-115879
Closed Access | Times Cited: 6
Poly(hydroxamic acid) resins and their applications
Md Lutfor Rahman, Mohd Sani Sarjadi, Shaheen M. Sarkar, et al.
Coordination Chemistry Reviews (2022) Vol. 471, pp. 214727-214727
Closed Access | Times Cited: 10
Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents
Xinran Cao, Yufeng Gong
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 469-492
Open Access | Times Cited: 1
Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy
Hualong Mo, Jie-Ying Liu, Zhengxi Su, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116765-116765
Closed Access | Times Cited: 1
Discovery of a Series of Hydroxamic Acid-Based Microtubule Destabilizing Agents with Potent Antitumor Activity
Linyu Yang, Wanhua Zhang, Qiang Qiu, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 20, pp. 15379-15401
Closed Access | Times Cited: 12
A comparative study on the metal complexes of an anticancer estradiol-hydroxamate conjugate and salicylhydroxamic acid
János P. Mészáros, Hilda Kovács, Gabriella Spengler, et al.
Journal of Inorganic Biochemistry (2023) Vol. 244, pp. 112223-112223
Closed Access | Times Cited: 4
Hydroxamic Acids as PARP‐1 Inhibitors: Molecular Design and Anticancer Activity of Novel Phenanthridinones
Denys Bondar, Olga Bragina, Ji Young Lee, et al.
Helvetica Chimica Acta (2023) Vol. 106, Iss. 10
Open Access | Times Cited: 3
Discovery and Optimization of Selective Inhibitors of Meprin α (Part I)
Shurong Hou, Juan Diez, Chao Wang, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 203-203
Open Access | Times Cited: 7
Dielectric barrier discharge plasma-coupled rare-earth modified Er3+-BiOI catalytic materials for degradation of organic pollutant benzohydroxamic acid in mineral beneficiation waster: Performance, degradation pathway, and its mechanism
Bingyan Dong, Zhendong Li, Peixiang Wang, et al.
Journal of Water Process Engineering (2023) Vol. 56, pp. 104393-104393
Closed Access | Times Cited: 2
Quinoline‐based thiazolyl‐hydrazones target cancer cells through autophagy inhibition
Vladimir Ćurčić, Mateusz Olszewski, Natalia Maciejewska, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Closed Access | Times Cited: 2
Design and Synthesis of Novel Podophyllotoxins Hybrids and the Effects of Different Functional Groups on Cytotoxicity
Zhong‐Tao Yang, Zitong Zhou, Xiai Luo, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 220-220
Open Access | Times Cited: 6
Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia
Ruiheng Wang, Shufeng Xie, Shouhai Zhu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents
Işıl Nihan Korkmaz, Hasan Özdemіr
Applied Biochemistry and Biotechnology (2022) Vol. 194, Iss. 12, pp. 6349-6366
Closed Access | Times Cited: 4
Cancer and brassinosteroids: Mechanisms of action, SAR and future perspectives
Marcos Lorca, David Cabezas, Ileana Araque, et al.
Steroids (2022) Vol. 190, pp. 109153-109153
Closed Access | Times Cited: 4
Synthesis and histone deacetylases inhibitory activity of pyrimidine‐based 1,3,4‐oxadiazoles
Virginija Jakubkienė, I. Labalaukyte, Markus Schweipert, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 9, pp. 1426-1438
Closed Access
Synthesis and Biological Evaluation of 4-Thiazolidinone Scaffold: A Versatile Chemistry and Diverse Biological Applications in the Drug Discovery and Development
Nisheeth C. Desai, Dharmpalsinh J. Jadeja, Keyur N. Shah, et al.
(2024), pp. 17-103
Closed Access
Photoinduced Copper‐Catalyzed Three‐Component Radical Carboamination of Styrene Derivatives
Xiao-Die Huan, Juan Zhang, Wenjing Xiao, et al.
ChemCatChem (2024) Vol. 16, Iss. 23
Open Access
Biosynthesis of iron-chelating terramides A-C and their role in Aspergillus terreus infection
Yi Han, Yaojie Guo, Nan Zhang, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top